These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 558542)

  • 21. Role of biogenic amines in morphine dependence in the rat.
    Schwartz AS; Eidelberg E
    Life Sci I; 1970 Jun; 9(11):613-24. PubMed ID: 5465644
    [No Abstract]   [Full Text] [Related]  

  • 22. The role of biogenic amines in the reserpine-induced alteration of minimal electroshock seizure thresholds in the mouse.
    Wenger GR; Stitzel RE; Craig CR
    Neuropharmacology; 1973 Jul; 12(7):693-703. PubMed ID: 4147164
    [No Abstract]   [Full Text] [Related]  

  • 23. Studies on psychotropic drugs. XX. Effects of 1-methyl-5-o-chlorophenyl-7-ethyl-1,2-dihydro-3H-thieno[2,3-e][1,4]diazepin-2-one (Y-6047) on the metabolism of biogenic amines.
    Nakanishi M; Setoguchi M
    Arzneimittelforschung; 1972 Nov; 22(11):1914-8. PubMed ID: 4267010
    [No Abstract]   [Full Text] [Related]  

  • 24. Studies related to the cholinergic influence on the accumulation and disappearance of monoamines in rat brain.
    Bhatnagar SP
    Can J Physiol Pharmacol; 1973 Dec; 51(12):893-9. PubMed ID: 4777240
    [No Abstract]   [Full Text] [Related]  

  • 25. Biogenic amines and behavior.
    Baldessarini RJ
    Annu Rev Med; 1972; 23():343-54. PubMed ID: 4577380
    [No Abstract]   [Full Text] [Related]  

  • 26. Strain differences in the analgesic response to morphine as measured on the hot plate.
    Gebhart GF; Mitchell CL
    Arch Int Pharmacodyn Ther; 1973 Jan; 201(1):128-40. PubMed ID: 4717379
    [No Abstract]   [Full Text] [Related]  

  • 27. Biochemical and behavioural changes induced by isolation in rats.
    Valzelli L; Garattini S
    Neuropharmacology; 1972 Jan; 11(1):17-22. PubMed ID: 5062183
    [No Abstract]   [Full Text] [Related]  

  • 28. A study of the central effects of 5,6-dihydroxytryptamine.
    Longo VG; Scotti de Carolis A; Liuzzi A; Massotti M
    Adv Biochem Psychopharmacol; 1974; 10():109-20. PubMed ID: 4546514
    [No Abstract]   [Full Text] [Related]  

  • 29. Dissociation of increased 5-hydroxyindoleacetic acid levels and physical dependence: the effects of naloxone.
    Laska FJ; Fennessy MR
    Clin Exp Pharmacol Physiol; 1977; 4(6):515-23. PubMed ID: 563313
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methyl methacrylate induced behavioural and neurochemical changes in rats.
    Husain R; Srivastava SP; Seth PK
    Arch Toxicol; 1985 Oct; 58(1):33-6. PubMed ID: 4074128
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biochemical and behavioural alterations following 5,6-dihydroxytryptamine administration into brain.
    Breese GR; Cooper BR; Grant LD; Smith RD
    Neuropharmacology; 1974 Mar; 13(3):177-87. PubMed ID: 4407423
    [No Abstract]   [Full Text] [Related]  

  • 32. Drug-induced brain monoamine depletion and its behavioral correlates in Caiman sclerops.
    Doshi E; Huggins SE
    Comp Biochem Physiol C Comp Pharmacol; 1977; 57(2):153-7. PubMed ID: 20272
    [No Abstract]   [Full Text] [Related]  

  • 33. Alterations in behavior and brain catecholamine levels in rats treated with alpha-methyltyrosine.
    Rech RH; Borys HK; Moore KE
    J Pharmacol Exp Ther; 1966 Sep; 153(3):412-9. PubMed ID: 5922318
    [No Abstract]   [Full Text] [Related]  

  • 34. Actions of atropine, hemicholinium-3, and physostigmine on chlorpromazine-induced changes in rat brain monoamines.
    Bhatnagar SP
    Can J Physiol Pharmacol; 1974 Jun; 52(3):500-7. PubMed ID: 4152758
    [No Abstract]   [Full Text] [Related]  

  • 35. The effects of 3- -dimethylaminopropyl-3-phenylphthalide (I.C.I. 53,165) on brain monoamines and their precursors.
    Leonard BE
    Arch Int Pharmacodyn Ther; 1972 Sep; 199(1):94-107. PubMed ID: 5072195
    [No Abstract]   [Full Text] [Related]  

  • 36. Interactions of imipramine and synthesis inhibitors on biogenic amines.
    Friedman E; Shopsin B; Goldstein M; Gershon S
    J Pharm Pharmacol; 1974 Dec; 26(12):995-6. PubMed ID: 4156872
    [No Abstract]   [Full Text] [Related]  

  • 37. A comparison of the neurochemical effects of buprenorphine with those of morphine and haloperidol in rats.
    Dettmar PW; Cowan A; Walter DS
    Eur J Pharmacol; 1981 Jan; 69(2):147-53. PubMed ID: 7202515
    [No Abstract]   [Full Text] [Related]  

  • 38. Reuptake of biogenic amines by brain slices: effect of hydrocortisone.
    Lieberman KW; Stokes PE; Fanelli CJ; Klevan T
    Psychopharmacology (Berl); 1980; 70(1):59-61. PubMed ID: 6775336
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroanatomical and chemical correlates of naloxone-precipitated withdrawal.
    Way EL; Loh HH; Ho IK; Iwamoto ET; Wei E
    Adv Biochem Psychopharmacol; 1973; 8(0):455-69. PubMed ID: 4604812
    [No Abstract]   [Full Text] [Related]  

  • 40. DOPA potentiation in ablated animals and brain levels of biogenic amines in intact animals after prolyl-leucylglycinamide.
    Plotnikoff NP; Minard FN; Kastin AJ
    Neuroendocrinology; 1974; 14(5):271-9. PubMed ID: 4858836
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.